Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation

Duarte, A, Mebrahtu, T orcid.org/0000-0003-4821-2304, Goncalves, PS et al. (6 more authors) (2017) Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation. Health Technology Assessment, 21 (64). pp. 1-244. ISSN 1366-5278

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Queen’s Printer and Controller of HMSO 2017. This work was produced by Duarte et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.
Dates:
  • Accepted: 1 June 2017
  • Published: November 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Translational Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Feb 2018 11:30
Last Modified: 23 Feb 2018 11:30
Status: Published
Publisher: NIHR Health Technology Assessment Programme
Identification Number: https://doi.org/10.3310/hta21640
Related URLs:

Share / Export

Statistics